CD274 and non-small cell lung carcinoma: In lung adenocarcinoma and non-small cell lung cancer (NSCLC), CD73 expression is linked to elevated PD-L1 levels and an increase in tumor-associated immune cells, contributing to an immunosuppressive microenvironment (74, 76, 82–86).